Matsuda T, Tanaka Y, Takeshita N, Ishiwata J, Awane Y
Gan To Kagaku Ryoho. 1987 May;14(5 Pt 2):1508-14.
Sixty-eight cases of cancer were treated by combined use of Thermotron RF-8 hyperthermia and radiotherapy, and 16 cases by combined use of hyperthermia and anti-cancer drug. The results of analysis of treatment are summarized as follows. Thermo-radiotherapy of shallow-seated tumor: Shallow-seated tumor at a depth of 7 cm or less from the skin surface was present in 43 cases. Most of these were metastatic tumors of lymph node, chest wall and abdominal wall. Pathological findings and primary effect; The effect of treatment was evaluable in 40 cases, the breakdown being as follows: CR 21 cases 53%, PR 13 cases 40%, and NR 3 cases 7%. The effectiveness ratios (CR/PRa) were as follows: adenocarcinoma 13 cases out of 18, 72%; squamous cell carcinoma 12 cases out of 15, 80%. The effectiveness ratios were thus almost the same. Tumor size and primary effect: Out of 19 cases of tumor 5.9 cm or smaller, 17 cases obtained CR. Out of 17 cases of tumor 6 cm or larger, there were 5 cases of CR. Cases of larger-sized tumor thus showed a poorer effect of treatment. Recurrence after radiotherapy: Nine cases of recurrence after radiotherapy were treated by combined use of hyperthermia and radiotherapy. Irradiation of 20 to 40 Gy was combined with 5 to 10 rounds of hyperthermia. The effectiveness ratio was 78%, i.e., 7 cases out of 9. Cases of recurrence of radio-resistant tumor after radiotherapy responded well to low-dose irradiation. Thermo-radiotherapy of deep-seated tumor: Twenty-two cases of deep-seated tumor were treated with the combined use of radiation therapy and hyperthermia. They comprised 10 cases of rectal cancer, 3 cases each of gastric cancer and uterine cancer, 2 cases each of lung cancer and sarcoma, and 2 cases involving other regions. The treatment results were: 3 cases each of CR, 15 cases of PR, and 4 cases of NR. The effectiveness ratio (CR + PRa) was 8 cases out of 22, i.e., 36%. Thermo-chemotherapy: Systemic administration of anti-cancer drug was combined with hyperthermia, and 16 cases were treated. They comprised 11 cases of gastric cancer, 3 cases of colo-rectal cancer, and one case of bile duct cancer. The administered drug was 5-FU in 8 cases, MMC in 7 cases, and CDDP in one case. The treatment results were; one case of CR, 4 cases of PR, 6 cases of MR, 3 cases of NC, and 2 cases of PD. More cases of lymph node tumor showed excellent results.
68例癌症患者采用Thermotron RF - 8热疗与放疗联合治疗,16例患者采用热疗与抗癌药物联合治疗。治疗分析结果总结如下。浅表肿瘤的热放疗:43例患者存在位于皮肤表面7厘米及以下深度的浅表肿瘤。其中大多数是淋巴结、胸壁和腹壁的转移瘤。病理结果和初步疗效;40例患者的治疗效果可评估,具体情况如下:完全缓解(CR)21例(53%),部分缓解(PR)13例(40%),无缓解(NR)3例(7%)。有效率(CR/PRa)如下:腺癌18例中有13例,占72%;鳞状细胞癌15例中有12例,占80%。因此有效率几乎相同。肿瘤大小与初步疗效:肿瘤直径5.9厘米及以下的19例患者中,17例获得完全缓解。肿瘤直径6厘米及以上的17例患者中,有5例完全缓解。因此,肿瘤较大的患者治疗效果较差。放疗后复发:9例放疗后复发的患者采用热疗与放疗联合治疗。20至40戈瑞的放疗联合5至10次热疗。有效率为78%,即9例中有7例。放疗后抗辐射肿瘤复发的患者对低剂量放疗反应良好。深部肿瘤的热放疗:22例深部肿瘤患者采用放疗与热疗联合治疗。其中包括10例直肠癌、3例胃癌和子宫癌、2例肺癌和肉瘤,以及2例其他部位肿瘤。治疗结果为:完全缓解3例,部分缓解15例,无缓解4例。有效率(CR + PRa)为22例中有8例,即36%。热化疗:抗癌药物全身给药联合热疗,治疗16例患者。其中包括11例胃癌、3例结直肠癌和1例胆管癌。给药药物8例为5 - 氟尿嘧啶,7例为丝裂霉素,1例为顺铂。治疗结果为:完全缓解1例,部分缓解4例,好转6例,病情稳定3例,病情进展2例。更多淋巴结肿瘤患者显示出良好效果。